Australia Approves Second Treatment for Geographic Atrophy
Astellas' IZERVAY® (avacincaptad pegol) has been approved for use in Australia by the TGA Astellas...
The Economic and Psychosocial Impact of Caring for Families Affected by Visual Impairment (EPIC-Vision) Study
Visual impairment resulting from inherited retinal dystrophy (IRD) has...
World Research Summary by Dr Catherine Civil
Hot Off The Press There are just a couple of articles for you this month, but I hope you find...
World Retina Day 2025
Every year, World Retina Day shines a spotlight on the millions of people living with inherited retinal diseases and other retinal dystrophies. These conditions affect not only vision, but...
World Research Summary by Dr Catherine Civil
Hot Off The Press Check out below to see what new inherited retinal disease (IRD) therapies are in the pipeline. I...
Have your say – First GA treatment being considered for PBS subsidy
Do you have geographic atrophy? If you or someone close...
World Research Summary by Dr Catherine Civil
Hot Off The Press Check out below to see what new inherited retinal disease (IRD) therapies are in the pipeline. I...
EMA Survey – Input from People Living with Retinitis Pigmentosa
Invitation to participate Through Retina Australia's membership with Retina International,...
World Research Summary by Dr Catherine Civil
Hot Off The Press Check out below to see what new inherited retinal disease (IRD) therapies are in the pipeline. There...
Research Grant Impact Highlight: Associate Professor Raymond Wong
Associate Professor Raymond Wong, from the Centre for Eye...
Research Updates on Inherited Retinal Diseases: ARVO 2025 Summary
For those living with inherited retinal diseases (IRDs), and...
New Research: The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes
X-linked retinitis pigmentosa (XLRP) is considered one of the...
New Research: The Impacts of Caregiving for Patients with X-Linked RP
X-linked retinitis pigmentosa (XLRP) is considered one of the...
New Research: Dismantling barriers to research and clinical care for individuals with a vision impairment
People with vision impairment face limited access to research...
X-linked retinitis pigmentosa RPGR gene therapy study update
The LUMEOS study was sponsored by Janssen Research & Development, LLC (a division of...
World Research Summary by Dr Catherine Civil
Hot Off The Press Check out below to see what new inherited retinal disease (IRD) therapies are in the pipeline! Base...
Podcast: Mental Health and Rare Eye Diseases
Perspectives Podcast by Retina International Guest speaker: Matt Bolz-Johnson, a mental health lead at EURORDIS-Rare Diseases Europe Retina International's Perspectives Podcasts...
New Research: Navigating a hidden disability – Lived experiences and challenges of adults with early stage inherited retinal diseases
Inherited retinal diseases (IRDs) are genetic conditions that typically...
Perspectives of stem cell therapies for retinal conditions
Retina Australia has partnered with researchers at the University of New South Wales to...
AAV-Based Gene Therapy for Retinal Diseases: A 2025 update
Retina Australia 2025 grant awardee, Dr Jiang-Hui (Sloan) Wang, PhD (Research Fellow), from the...